Cassidy targets 340B, Eli Lilly's mysterious retatrutide patient, and more biotech news from The Readout

Scientists can’t ignore the ethical complexities of new embryo editing advances.

Ethical discussions are urgently needed as genome-editing science advances, some researchers say.